Trial Profile
Clinical Trials Insight: 700030157
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2008
Price :
$35
*
At a glance
- Drugs Melogliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 29 Jan 2008 New trial record.